![Matthew J. Giacalone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew J. Giacalone
Geschäftsführer bei Vaxiion Therapeutics, Inc.
Profil
Dr. Matthew J.
Giacalone is Vice President-Development & Research at Vaxiion Therapeutics, Inc.
He received his undergraduate degree from San Diego State University, an MBA from the University of California, San Diego, and a doctorate degree from San Diego State University.
Aktive Positionen von Matthew J. Giacalone
Unternehmen | Position | Beginn |
---|---|---|
Vaxiion Therapeutics, Inc.
![]() Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Geschäftsführer | - |
Ausbildung von Matthew J. Giacalone
San Diego State University | Doctorate Degree |
University of California San Diego | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Vaxiion Therapeutics, Inc.
![]() Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Health Technology |